LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | R406 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3054 | 4156 | 0.7348 | 0.6227 |
MCF7 | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1191 | 4156 | 0.2866 | -0.0151 |
MCF7 | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 4423 | 4156 | 1.0642 | 1.0914 |
MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1297 | 4156 | 0.3122 | 0.0213 |
MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1242 | 4156 | 0.2988 | 0.0023 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1063 | 4156 | 0.2559 | -0.0588 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1156 | 4156 | 0.2783 | -0.0270 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1945 | 4156 | 0.4681 | 0.2431 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1053 | 4156 | 0.2535 | -0.0622 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2231 | 4156 | 0.5369 | 0.3410 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1328 | 4156 | 0.3196 | 0.0318 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1371 | 4156 | 0.3300 | 0.0467 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1501 | 4156 | 0.3612 | 0.0909 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 4335 | 4156 | 1.0432 | 1.0615 |
MCF7 | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1064 | 4156 | 0.2560 | -0.0587 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1581 | 4156 | 0.3806 | 0.1186 |
MCF7 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3964 | 4156 | 0.9538 | 0.9342 |
MCF7 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2191 | 4156 | 0.5272 | 0.3272 |
MCF7 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3842 | 4156 | 0.9246 | 0.8927 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2187 | 4156 | 0.5263 | 0.3259 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1235 | 621 | 4156 | 0.1496 | -0.2101 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1235 | 660 | 4156 | 0.1589 | -0.1969 |
MCF7 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1414 | 4156 | 0.3403 | 0.0613 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2031 | 4156 | 0.4888 | 0.2725 |
MCF7 | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4349 | 4156 | 1.0466 | 1.0662 |